Welcome to the 2001 online abstracts section. Here you can view abstracts that were presented at the CACMID 2001
meeting in Victoria, B.C. Nov. 4 - 8, 2001.
To view the abstracts by subject, click on one of the topics below.
Click here to go back to Abstracts Main Page
Mycology
Mycobacteria
Virology
Influenza
HIV; HSV
Hepatitis B; C
Bacteriology
MRSA
VRE
Pneumococci
Chlamydia
Gonococci
Respiratory Infections
Enteric Bacterial Disease
Diagnosis; Prevention of Meningitis
Emerging Bacterial Pathogens
Antimicrobials
Parasitology; Vector Borne Disease
Surgical Site Infections
Planning for Microbiology Challenges
Evaluations of Automated Equipment
Quality Assurance
Infection Control
Student Posters
To view the abstracts by subject, click on one of the topics below.
Click here to go back to Abstracts Main PageMycology
(back to top)
P 45 Epidemiology of Onychomycosis in Saskatchewan, Canada
H. CONGLY* and G. HORSMAN, Provincial Laboratory, Regina, Saskatchewan, Canada
P 46 Infection Control Measures Following Aspergillus Infections on an Acute Oncology Ward PIASKOWSKI,P.,* HUGHES,K., TITTLEY,N., Thunder Bay Regional Hospital, Thunder Bay, ON
P 47 Fungal rDNA Sequence-based Identification of an Atypical Yeast Isolate from a Blood Culture of an Ontario Patient Receiving Prolonged Antifungal Chemotherapy
LI A.*, CIEBIN B., JAMIESON F. Central Public Health Laboratories, Ontario Ministry of Health and Long-Term Care, Toronto, Ontario
P 48 Penicillium sp. in Blood Cultures on a Haematology-Oncology Unit
B. SUTHERLAND, G. TAYLOR, R. RENNIE, C. SAND University of Alberta Hospital and University of Alberta
P 99 Hospital Construction: The Fungus Among Us
P. ORENSTEIN*, N. CONSOLACION, B. AMIHOD, M.A. MILLER, SMBD-Jewish General Hospital, Montreal, Quebec
Mycobacteria
(back to top)
M 1 Calgary Health Region Tuberculosis Screening for Admission to Supported Living: Process Review
K. RASMUSSEN, N. ALFIERI. Infection Prevention and Control, Calgary Health Region, Calgary, AB.
M 2 Health Care for People with Leprosy: Experience in Three Facilities in Northern Thailand
RATZLAFF, JACKIE I., Vancouver Hospital & Health Sciences Centre, Division of Medical Microbiology and Infection Control, Vancouver, British Columbia
M 3 Complex Case Management of Multi-drug Resistant Mycobacterium tuberculosis (MDR TB)
CALLERY, S. ,* GRIFFITHS-TURNER, M. , TOLOMEO, O. , BUFFETT, C. , FEIGHTNER, K. DOWHAN-SOLTYS, S. , DAWSON, M. , PIERCE, M. , CIVIDINO, M. , WHITEHEAD, L. RICHARDSON, E. St. Joseph's Healthcare, Hamilton Ont.; Social and Public Health Services Department, Communicable Disease Control Branch, Hamilton Ont.
M 5 Evaluation of an In-house PCR for Identification of Mycobacterium xenopi in Culture Positive Specimens.
A. PETRICH*, K. LUINSTRA, J. BABU and P. DRUMMOND. St. Joseph’s Healthcare, Hamilton Health Sciences-McMaster Site, Hamilton, ON.
P 77 Evaluation of DNA Extraction Methods for Mycobacterium avium subsp. paratuberculosis
L. CHUI*, R. KING, K. MANNINEN and J. SIM. Provincial Laboratory for Public Health (Microbiology); Alberta Agriculture, Food and Rural Development, and Agricultural Food and Nutritional Sciences, University of Alberta, Edmonton, Alberta.
P103 (Originally scheduled as M 4) Genes Differentially Expressed by Anaerobic Mycobacterium tuberculosis
D. Y. KUNIMOTO*, F. ZHONG Dept. of Medicine, University of Alberta, Edmonton, AB
Virology
(back to top)
B2 Comparison of R-Mix (MinkLung/A549) Cells and Traditional Tissue Culture for Rapid Detection of Respiratory Viruses G.McNABB*,D.LAWRENCE,R.GILLIES,B.HOY, T.HO,R.MA,D.COOK,M.KRAJDEN.British Columbia Centre for Disease Control
B3 Epidemiology and Seasonality of Viral Respiratory Tract Infections in Hong Kong JS TAM, PKS CHAN, R LAM, TF FOK*, EAS NELSON*, KC NG and AF CHENG
Depts. of Microbiology & Paediatrics*, The Chinese University of Hong Kong, Hong Kong.
B5 Chemicon respiratory panel 1 viral screening and idenfication IFA is equivalent to Bartels VRK IFA kit in the detection and identification of respiratory viruses in viral culture R.GARCEAU1*, L.THIBAULT1. 1Laboratoire de microbiologie, L'Hopital Regional Dr G.L. Dumont, Moncton, NB.
K 1 Structure of Replicative Intermediates of Human Herpesvirus 6
ALBERTO SEVERINI* and GRAHAM TIPPLES. National Microbiology Laboratory, Health Canada, Winnipeg, MB
K 2 Varicella-zoster virus genotyping G.A. TIPPLES1*, J. HIEBERT1, L.E. MARANAN1, D. COOK2 and R. GARCEAU3
1Viral Exanthemata, National Microbiology Laboratory, Winnipeg, Manitoba, 2BC Center for Disease Control, Vancouver, BC, and 3L'Hopital Regional Dr GL Dumont, Moncton, New Brunswick.
K 3 Identification of an Imported Case of Hantavirus Pulmonary Syndrome (HPS) from Argentina
M. DREBOT, J. DOYLE, K. HOLLOWAY, S. MALAN, H. ARTSOB, and E. PRASAD. Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, PPHB, Health Canada, Winnipeg, MB and Alberta Provincial Laboratory for Public Health (Microbiology), Edmonton,AB.
K 4 Application of DNA Chip Technology for Genotyping Hantavirus Infected Deer Mice
S.BOOTH*, M.DREBOT.Host Genetics and Prion Diseases / Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, PPHB, Health Canada, Winnipeg, MB.
K 5 Anti-viral Activity of Cidofovir In Vitro and In Vivo Against Adenovirus Isolated from Severe Pneumonitis.
S. CASTRICIANO*, M. SMIEJA. McMaster University, St. Joseph’s Healthcare, Hamilton, ON.
P 54 Risk of Cytomegalovirus (CMV) Transmission by Pancreatic Islet Transplantation
PREIKSAITIS JK.*LEBLANC B. SHAPIRO J. LAKEY J. RYAN E. FENTON J. BIGAM D. KNETEMAN N.
Microbiology Public Health Laboratory, University of Alberta Hospital, Departments of Medicine and Surgery, University of Alberta, Edmonton, Alberta, Canada.
P 57 Waning Immunity to Rubella in Vaccinated Adult Population: A Cause of for Public Health Concern
S. RATNAM *1, C. HEAD1 AND C. O'KEEFE2. 1Provincial Public Health Laboratory, 2Division of Disease Control and Epidemiology, Dept. of Health and Community Services, St. John's, NF
Q1 West Nile Surveillance in Ontario, Canada; Summer and Fall 2000
I. GUGLIELMI1, M. FEARON1, C. LEBER2, L. FORD-JONES3, D. ALVES4, I. BARKER5, R. ROSATTE6, R. LINDSAY7, J. HEAL5, G. CUTTEN8, H. ARTSOB71Ontario Ministry of Health and Long Term Care, Laboratories Branch; 2Public Health Branch, Toronto, Ont.; 3The Hospital for Sick Children, Toronto, Ont.; 4Ontario Ministry of Agriculture, Food and Rural Affairs, Fergus, Ont.; 5University of Guelph, Guelph, Ont.; 6Ministry of Natural Resources, Peterborough, Ont.; 7Health Canada, Winnipeg, Man.; 8 Ministry of Environment, Toronto, Ont.
Q2 Powassan virus: phylogenic studies from a Canadian perspective
H ARTSOB1*,& G KUNO2, N KARABATSOS2, K R TSUCHIYA2, J J CHANG2, M FEARON3, M. DREBOT1.
1National Microbiology Laboratory, Health Canada, Winnipeg, MB; 2Division of Vector-Borne Infectious Diseases, CDC, Fort Collins, CO; 3Ontario Ministry of Health and Long Term Care, Laboratories Branch, Toronto, ON
Q3 Molecular Characterization of Canadian Norwalk- and Sapporo-like Viruses Circulating During 1995-2000.
CAMPBELL, J.J.1,* LEE, S.H.S.1,2, FORWARD, K.R.1,2, CARPENTER M.S.1,2,National Centre for Enteroviruses1, QEII Health Sciences Center and Dept. of Microbiology & Immunology, Dalhousie University2, Halifax, N.S.
Q4 Evaluation of Electron Microscopy and RT-PCR Methods for Detection of Norwalk-like Viruses Associated with Gastroenteritis Outbreaks in BC
L. MCINTYRE1, S. BYRNE1, J. FUNG1, A. TRINIDAD1, and J. ISAAC-RENTON1, British Columbia Centre for Disease Control1, Vancouver, British Columbia, V5Z 4R4
Q5 Molecular Epidemiology of Norwalk-like Viruses Associated with Gastroenteritis Outbreaks in British Columbia
A.MCNABB, S.BYRNE, R.PARKES, L.MCINTYRE, J.FUNG, A.TRINIDAD, AND J.ISAAC-RENTON.
British Columbia Centre for Disease Control and University of British Columbia. Vancouver, British Columbia.
U 3 Evaluation of 4 Commercial EIA Assays for 3 serological markers for Epstein-Barr virus: EBVCA IgM, EBVCA IgG and EBNA
LEE B.*, FENTON J., BENEDET M., CHOW A., PREIKSAITIS J. Provincial Laboratory for Public Health (Microbiology), Edmonton, Alberta.
U4 Comprehensive Detection and Serotyping of Human Adenoviruses by PCR and Sequencing
H. SARANTIS, G. JOHNSON, M. BROWN, M. PETRIC, *R. TELLIER. The Hospital for Sick Children and The University of Toronto, Toronto, Ontario.
U5 Direct Rotavirus Testing with Rotascreen Dipstick of Specimens Received in Bacterial, Viral and Parasite Transport Media
F. E. CAHOON1, 2, D. R. GATES-DAVIS1, J. STUBBERFIELD4, M. CARDONA, M. FEARON4 and J. S. THOMPSON5
Ontario Ministry of Health, Peterborough Public Health Laboratory1, Peterborough ON, Orillia Public Health Laboratory2, Orillia ON, Toronto Public Health Laboratory4, Toronto ON and Med-Ox Diagnostics Inc.5, Kanata ON.
Influenza
(back to top)
C 1 A comprehensive approach to influenza (FLU) prevention and management
E.HENDERSON*, W.LAU, K.RASMUSSEN, E.SIMMONDS, M.TARRANT, N.ALFIERI, M.LEBLANC, K.FONSECA L.ALDRIDGE P.QUAIL, T.LOUIE. Calgary Health Region University of Calgary, Calgary, Alberta
C 2 Infection Control Programs for Influenza in Canadian Acute Care Hospitals
ZOUTMAN, D.,* FORD, D., Queen's University
C 3 Are Hospital-Based Vaccination Programs Beneficial: a Canadian Hospital Experience
A. MCGEER*, L. BERRIE, M. MCARTHUR, J. SLOGGETT, M. GARDAM, C. MOORE., Mount Sinai Hosp., Univ. Health Network.
C 4 Influenza Vaccine Compliance: Targeting Refusals
*LAALO,J.,MARTIN,N.,GLAVIN,V.,AGARD,M., Cambridge Memorial Hospital,Cambridge, Ont.
C 5 Influenza Immunization Coverage in Long-Term Care Facilities and Hospitals in Ontario, 2000/01
E. ABRAHAM*, M. NAUS, M. VARIA, G. POHANI. Disease Control Service, Public Health Branch, Ministry of Health and Long-Term Care, Toronto, ON
B 1 Is the BD Directigen Flu A+B kit able to detect Influenza in throat swabs submitted for Influenza antigen detection and culture?
R. GARCEAU1,*L. THIBAULT1, M. MALLET2 and G.L. Dumont2. 1Laboratoire de microbiologie, L’Hopital Regional 2 Pahes et Oceans Canada, Moncton, NB.
B4 Comparison of Becton Dickinson’s Directigen Flu A+B Kit with Viral Culture for the Detection of Influenza B.
MILLEY, D.,* KLISKO, B., VAN CAESEELE, P. Cadham Provincial Laboratory, Winnipeg, MB.
P 55 Influenza Campaign 2000, A PR Success Story
C. MUNFORD*, L. PETERSON, L. POFFENROTH, and J. TOBO
HIV HSV
(back to top)
E 1 Comparison of Two HIV Enzyme Immunoassay Tests based on Antibody Titre and Avidity to Detect Early HIV Infections in Cross-Sectionally Obtained Serology Samples
L. MALLOCH, B. CALDER-KENT, G. JAYARAMAN, C. ARCHIBALD, P. UHTHOFF, P. SANDSTROM, J.E.KIM * and PROVINCIAL LAB STAKEHOLDERS IN THE CANADIAN HIV INTEGRATED SURVEILLANCE PROGRAM. National Laboratory for HIV Reference Services, Divisions of HIV Epidemiology and Retrovirus Surveillance, Health Canada, Ottawa, ON
E 2 Results from the Ontario Pilot HIV Genotyping Program
C SWANTEE1, C MAJOR1, R REMIS2, M FEARON1, K WU1, A BAYOUMI2, A RACHLIS2, R KORT1, F MCGEE1, R GALLI3, RA HARRIGAN3, S READ2, and the Ontario HIV Genotyping Working Group. Ontario Ministry of Health and Long-Term Care1, University of Toronto2 , BC Centre for Excellence in HIV/AIDS3.
E 3 Effect of Limiting HIV Viral Load in Accurate Base Calling and Interpretation of HIV Drug-Resistance Mutations using a Commercial HIV Genotyping Assay
Z. CHEN and J.E.KIM * National Laboratory for HIV Reference Services, Health Canada, Ottawa, ON
E 4 Evaluation of the MedMira and FastCheck HIV 1/2 Rapid HIV Screen Tests in a Rapid Response Laboratory
PREIKSAITIS JK.* FENTON J. VERITY B. GALBRAITH J. JOFFE M. BLONDEL-HILL E. Provincial Laboratory of Public Health, Dynacare-Kasper Medical Laboratories, Royal Alexandra Hospital, Edmonton, Alberta, Canada.
E 5 Detection, Prevalence and Comparison of Drug Resistance Mutations in the Thymidine Kinase Gene of HSV-1 and HSV-2 from Clinical Samples
Z. CHEN, O. HSUEH, P.SANKAR-MISTRY AND J.E.KIM. Ontario Ministry of Health Laboratories, Ottawa, ON, National HIV Reference Services Lab, Health Canada, Ottawa, ON
P 89 Resolution of Problematic PCRs J. MIHOWICH * and J.E. KIM. National Laboratory for HIV Reference Services (NLHRS), Health Canada, Ottawa, ON.
P 100 Comparison of Two Confirmatory Assays for HSV on Samples from a High-Risk Cohort Previously Unresolvable by Subtype-Specific HSV EIA kits
L. MALLOCH, Y. COTE, G. FORTIER, B. CALDER-KENT, T. WONG, S. SHIELDS, AND J. E. KIM*, Bureau of HIV/AIDS, STD and TB, Health Canada, Ottawa, ON, Biochem Immunosystems, Montreal, QC.
U 1 Herpes Simplex Seroprevalence in Newfoundland Women
S. RATNAM1*, C. HEAD1, M. CHERNESKY2, S. SACKS3 and S. SHIELDS4 1 Public Health Laboratory, St. John's, NF; 2 St. Joseph's Hospital, Hamilton, ON; 3 Viridae Clinical Sciences Inc., Vancouver, BC; 4 Bureau of HIV/AIDS, STD & TB, Health Canada, Ottawa, ON.
U 2 Evaluation of Two Commercial Herpes Simplex Virus 1 (HSV-1) and Herpes Simplex Virus 2 (HSV-2) Type-Specific Immunoglobulin G (IgG) ELISA Systems
E. PRASAD, J. FENTON, M. BENEDET, L. MYZIUK, B. ROMANOWSKI and J. PREIKSAITIS. Provincial Laboratory for Public Health (Microbiology) and Division of Infectious Diseases, University of Alberta Hospital, Edmonton, Alberta, Canada.
Hepatitis B C
(back to top)
N 1 Hepatitis C Virus (HCV) Load Response To Interferon/Ribaviron Therapy In A Community-based Practice
S. G. M. WONG, F.H. ANDERSON, N. ROCK, L. WALSTON, K. GUNADASA, A. MAK, G. MCNABB, D. COOK, W. D. HILL, M. KRAJDEN. Vancouver Hospital Health Sciences Centre, British Columbia Centre for Disease Control and University of British Columbia.
N2 Evaluation of a Modified Sequence-based Method for HCV Genotyping
R.PARKES, G.MCNABB, P.COOK, M.KRAJDEN, S.K.BYRNE. British Columbia Centre for Disease Control. Vancouver, B.C.
N 3 Hepatitis C Virus (HCV) Genotyping; Pitfalls and Potential.
L.LIN*1, K.NICHOLSON2 and A.ANDONOV1 1Bloodborne Pathogens and Hepatitis, National Microbiology Laboratory, Health Canada1, Ontario Public Health Laboratory2
N 4 The Potential of the Ortho Total HCV Core Antigen Prototype Assay in Monitoring Progress of Therapy in HCV Patients
CHARLES TACKNEY5, L. ROMANO1, G. BELLATI2, M. BRUNETTO3, F. BONINO3, R. SOFFREDINI4, M. COLOMBO44, STEPHEN LEE5; A. ZANETTI1Instute of Virology, Univ. Milan; 2Ospedale di Mariano C.se; 3Ospedale di Pisa; 4Ospedale Maggiore IRCCS, Milano; 5Ortho Clinical Diagnostics Inc.
N 5 Health Related Quality of Life in HCV Infected Patients Receiving Rebetron
M. BOHUN, L.L. WALSTON, F.H. ANDERSON, M. KRAJDEN, W.D. HILL AND N. ROCK. Vancouver Hospital and Health Sciences Centre, University of British Columbia and BC Centre for Disease Control
P 6 Sensitive Detection of HBsAg Mutants by a Gap-Ligase Chain Reaction Assay
C. OSIOWY. *Bloodborne Pathogens and Hepatitis, National Microbiology Laboratory, Health Canada, Winnipeg, MB.
P 7 Hepatitis C: New Infections K.NICHOLAS*, G.HAWES, V.MUNRO,C DELIMA, T.MAZZILLI, M.FEARON, Ont. Min. of Health and Long Term Care. Toronto, Ont.
P 8 Geographic Information Systems (GIS) To Guide Hepatitis C Virus (HCV) Magement In British Columbia
W.D. HILL, S. MAK, D. PATRICK, L. ENGWER, F.H. ANDERSON, M. KRAJDEN. BC Centre for Disease Control, University of British Columbia and Vancouver Hospital and Health Sciences Centre.
P 9 Improving Tracking and Surveillance of Hepatitis B Immune Globulin
M. BIGHAM1, P. DOYLE 2,3, L. DePAOLI2, A. MANGAL3, D. PI4, J.MACNABB1,S. PECK5 1BC Centre for Disease Control (BCCDC), 2Canadian Blood Services (CBS), 3Vancouver Hospital and Health Sciences Centre, 4Provincial Blood Coordinating Office of BC Ministry of Health (PBCO), Vancouver, BC; and 5Office of the Provincial Health Officer (PHO), Victoria, BC.
P10 Perinatal Transmission Of Hepatitis B AND S-escape Mutants In Canada
S.G.M. WONG, M. KRAJDEN, M. ZHANG, M. DAWOOD, R.GERSTEIN, R. SCHREIBER, S. DOBSON, P. DOYLE, D. COOK, G. MCNABB, J. CAMPIONE-PICCARDO, A. GIULIVI, G.Y. MINUK. BC Centre for Disease Control, University of British Columbia, University of Manitoba, Canadian Blood Services.
Bacteriology
J 1 Evaluation of an Immunochromatographic Strip Test for the Detection of Diphtheria Toxin
E.Ongsansoy*, K. Bernard, D. Wiebe National Microbiology Laboratory (NML), Health Canada, Winnipeg , MB
P 53 Emergence of Polyclonal Bacteremia Due to Stenotrophomonas maltophilia
G.D. TAYLOR, M. BUCHANAN-CHELL, T. KIRKLAND, B. SUTHERLAND, G. TYRRELL, L. CHUI University of Alberta Hospital, and University of Alberta Edmonton, Canada
P 80 Evaluation of the Copan Diagnostics Easy-FlowTM Transport Swab Compared to Another Rayon Swab Utilizing Amies Agar Gel
T. MAZZULLI, P. LO, M. SKULNICK, P.W. MARSHALL*. Toronto Medical Laboratories/Mount Sinai Hospital, Toronto, Ontario, Canada
P 81 Evaluation of Swab Transport Systems for Recovery of Selective Facultative Bacteria
BEREND C. SCHIEVEN, D. FARRELL. Gamma-Dynacare Laboratories, London, ON Canada
P 82 Evaluation of New Easy-FlowTM Transport Swab (Copan Diagnostics Inc), Designed For Improved Sample Release, In Comparison With Regular Rayon Transport Swabs
MARILYN SARINA*, B. GANDHI, P. MERCURI. The Credit Valley Hospital, Mississauga, Ontario.
P 84 In vitro activity of quipristine/dalfopristine (Synercid, SYN), telithromycin (TELI), linezolid (LIN), erythromycin (ERY), and clindamycin (CLIN) against coagulase-negative staphylococci (CoNS)
Z. HUSSAIN, C. PLETCH, M. A. JOHN.
P 85 Comparison of fbAFLP and PFGE for Molecular Typing of Pseudomonas aeruginosa
NICK A. ANTONISHYN1*, RYAN R. McDONALD1, EDWARD L. CHAN1, GREG HORSMAN1, CARLA E. WOODMANSEE2, PAMELA S. FALK1, and C. GLEN MAYHALL1. Provincial Laboratory, Regina, Saskatchewan1 and UTMB, Galveston, Texas1.
P 86 Polymerase Chain Reaction Based (polA gene) Testing is More Sensitive than Dark Field Microscopy (DFM)/Direct Fluorescent Antibody (DFA) Assay for Detecting Treponema pallidum Genital Ulcer Disease
M. G. MORSHED 1,2,4; K. FERNANDO 1; Y. SIMPSON * 1; H. JONES 1; S. BYRNE 1,2,4; M. REKART 1,3,4; S. CHAMPAGNE 1,2,4; M. NOGUCHI 1 , R. BRUNHAM 1,3,4; J. ISAAC-RENTON 1,2,4. 1 Laboratory Services, BC Centre for Disease Control; 2 Department of Pathology and Laboratory Medicine, University of British Columbia (UBC); 3 Department of Medicine, UBC; 4 UBC Centre for Disease Control. 655 W 12th Avenue, Vancouver, V5Z 4R4.
MRSA
(back to top)
A 1 Prevalence of Methicillin-Resistant Staphylococcus aureus Among Injection Drug Users in an Inner City
P.C.DALY*1, E.A.BRYCE2, J.A.BUXTON3, S.WEATHERILL1. 1 Vancouver/Richmond Health Board 2 Vancouver Hospital and Health Sciences Centre and 3 Field Epidemiology Training Program, Health Canada
A 2 Laboratory Characterization of Methicillin-Resistant Staphylococcus aureus in Canadian Hospitals: The Results of Five Years of National Surveillance 1995-1999
A. E. SIMOR,1 M. OFNER-AGOSTINI,2 E. BRYCE,3 A. MCGEER,4 S. PATON,5 M. R. MULVEY,6 and THE CANADIAN NOSOCOMIAL INFECTION SURVEILLANCE PROGRAM, HEALTH CANADA.1 Sunnybrook and Women's College HSC;2 The University of Toronto, Toronto, Ont.;3 Vancouver General Hospital, Vancouver, BC;4 Mount Sinai Hospital; 5 the Division of Nosocomial and Occupational Infections, Centre for Infectious Disease Prevention and Control, Health Canada,6 National Microbiology Laboratory, Health Canada.
A 3 Methicillin-Resistant Staphylococcus aureus Treatment Patterns in Canada
CONLY J.C.,1* STIVER G.,2 WEISS K.,3 SCHLECH W.,4 LOUIE T.,5 BECKER D. L.,6 ROSNER A. J.,6 MILLER B.7 University of British Columbia, Vancouver, BC; 3University of Montreal, Montreal, QC; 4Dalhousie University, Halifax, NS; 5University of Calgary, Calgary, AB; 6Innovus Research Inc., Burlington, ON; 7Pharmacia Canada, Mississauga, ON.
A 4 Linezolid Activity against Resistant and Multidrug-Resistant Gram-Positive Clinical Isolates Collected across Canada in 2000-2001
K.A. WEISS 1, J.A. KARLOWSKY 2, L.J. KELLY 2, C. THORNSBERRY 2, M.E. JONES 3, I.A. CRITCHLEY 2, D.F. SAHM 2, Hopital Maisonneuve-Rosemont, Montreal Quebec1, and Focus Technologies/MRL, Herndon, Virginia USA2, and Hilversum, The Netherlands3
J 2 Comparison of Mannitol Salt Agar and MRSA Blue Agar, with 2 and 6 mg/L Oxacillin, for the Isolation of MRSA.
RUTHERFORD,C*., WILCOX, L., SMIEJA,M. HAMILTON REGIONAL LABORATORY MEDICINE PROGRAMME, DEPARTMENT OF PATHOLOGY, McMASTER UNIVERSITY, HAMILTON, ONTARIO.
J 3 Mannitol-negative Methicillin Resistant Staphylococcus aureus (mn-MRSA): Are You Missing Them?
C. MARTEL, K. RAMOTAR, C. OUELLET, P. JESSAMINE, B. TOYE, V. ROTH. The Ottawa Hospital and University of Ottawa, Ottawa, ON
J 5 Evaluation of a New Selective Media for Detecting Methicillin-Resistant Staphylococcus aureus (MRSA) from Screening Specimens
BM WILLEY*, C LAROCQUE, GW SMALL, R CRUZ, A GILL, B MUSTACHI, C REID, M SKULNICK, DE LOW, A MCGEER. TML and Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada
P 61 Development of Tools for the Implementation of a New Methicillin Resistant Staphylococcus aureus (MRSA) Protocol in a Recently Merged Multi-Site Institution
G. MORIN*, F. GASPARD, K. WADAS, J. JARAND, B. LUSSIER, S. PERNA, R. RODRIGUES, V. G. LOO
P 65 Common Source Outbreak of Methicillin Sensitive Staphylococcus aureus (MSSA) Meningitis Following Neurotologic Surgery
BARRY, C., VEARNCOMBE, M.,* RUPNARAIN, E., HILTON, M., CHEN, J., LOUIE, L., SIMOR, A., Departments of Microbiology and Otorhinolaryngology, Sunnybrook and Women's College Health Sciences Centre (SWCHSC), University of Toronto, Toronto, ON
P 66 A Multidisciplinary Team Approach Controls MRSA (Methicillin Resistant Staphylococcus aureus Transmission on an Acute Care of the Elderly (ACE) Unit
*WILSON, S., MCILVEEN, K.H., BOONE, J., WULFE, D., MORREL, L., STANLEY, J., JOFFE, A.M., Royal Alexandra Hospital, Edmonton, Alberta.
P 67 Appearance of Mupirocin-Resistant Staphylococcus aureus (MuRSA) in a Chronic Ambulatory Peritoneal Dialysis (CAPD) Population after 3 Years of Routine Mupirocin Exit Site Prophylaxis
H DEDIER*2, R ANNIGERI1, S FUNG1, S IZATT2, J BARGMAN2, S VAS2, D OREOPOULOS2, J CONLY1,2.Infection Prevention and Control Unit, University Health Network, Home Peritoneal Dialysis Unit, Toronto Western Hospital, Depts. Medicine1, and Microbiology2, University of Toronto, Toronto, Ontario
P68 Designing an Outbreak of Methicillin Resistant Staphylococcus aureus (MRSA)
V.R.OUELLET, C.D., BAILEY, E., SHYMANSKI, J., TAYLOR, M., JESSAMINE, P.G., ROTH, V.R. The Ottawa Hospital, Ottawa, ON
R 1 Effectiveness of Universal Screening Program Versus Targeted Screening for the Early Detection of Community-Acquired MRSA.
PERNA,SILVANA*, BEAUDRY, C., ZAKARATOS, J., LOO, V, McGill University, Montreal, QC.
R 2 Methicillin-resistant Staphylococcus aureus (MRSA) as a Cause of Infections in Domestic Animals: Evidence for a New Humanotic Disease?
MT OUGHTON*, HLN DICK, BM WILLEY, S BROWN, A MCGEER, B KREISWIRTH, DE LOW.TML and Mt. Sinai Hospital, Univ. of Toronto, Toronto, Vita-Tech Veterinary Lab., Markham, and Public Health Lab, Toronto, ON, Canada
R 3 Standardized Screening for MRSA
D.& THORNLEY*, A. BIALACHOWSKI, S. CALLERY, J. OLDE, F. SMAILL, M. LOEB Hamilton Health Sciences and St. Joseph's Healthcare, Hamilton, Ontario
R 4 Outbreak of Mupirocin-resistant MRSA (mr-MRSA) in a Community Hospital
F. LAING,* S. HENWICK and K. RAMOTAR. South Fraser Health Region, Surrey, BC and the Ottawa Hospital, Ottawa, Ontario.
R 5 The Costs and Consequences of Methicillin-Resistant Staphylococcus Species (MRSS) Infection Treatments in a Practice Setting in Canada
ROSNER A.J.,1 BECKER D.L.,1 WONG A.H,2 MILLER B.,2 CONLY J.C.,3* 1Innovus Research Inc., Burlington, ON; 2Pharmacia Canada, Mississauga, ON; 3University Health Network, University of Toronto, Toronto, ON
VRE
(back to top)
P 59 Incidence of vancomycin resistant enterococci (VRE) in Canada: Results from the Canadian Nosocomial Infection Surveillance Program (CNISP), 1998-2000
SHIRLEY PATON, Population and Public health Branch, Health Canada
P 60 A Regional Approach to MRSA and VRE Surveillance
K. FLUET, L.HANNA. Regional Public Health, Capital Health Region, Edmonton, Alberta and Good Samaritan Society, Edmonton, Alberta.
P 64 Survival of Epidemic and Non-epidemic Strains of VRE to Drying
S.D.PORTER, E.A.BRYCE, D.L.ROSCOE*,N.LIVESLEY Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia
P 88 MRSA and VRE: Antimicrobial Susceptibility Patterns of British Columbia Isolates
D.L.ROSCOE*1, E.A.BRYCE1, C. SHAW2, S. CHAMPAGNE2 AND MEMBERS OF THE BC ANTIMICROBIAL RESISTANCE SURVEILLANCE GROUP. Vancouver Hospital and Health Sciences Centre, 2 BC Centre for Disease Control Laboratory Services, Vancouver, British Columbia
P 97 MRSA and VRE: One Year of Provincial Surveillance
E.A.BRYCE*1,W.WOO2,S.CHAMPAGNE2,M.BIGHAM2 AND MEMBERS OF THE B.C. ANTIMICROBIAL RESISTANCE SURVEILLANCE GROUP. Vancouver Hospital and Health Sciences Centre1 and British Columbia Centre for Disease Control2
J 4 Etest May Produce Falsely Elevated Vancomycin MICs When Testing Enterococci
M. LOVGREN*, R. RENNIE, T. NG and G. TYRRELL Microbiology and Public Health, University of Alberta Hosp, Edmonton AB
Pneumococci
(back to top)
D 1 Increasing Resistance to the Macrolides in Streptococcus pneumoniae (Sp) Isolated from Nova Scotia
HILTZ, M.F., BETHUNE, R.N., ARBIQUE, J., HALDANE, D., FORWARD K., DAVIDSON, R.J.* Queen Elizabeth II Health Sciences Centre, Halifax, N.S
D 2 Invasive Pneumococcal Disease in BC: more can be achieved through immunization
PATRICK DM1, BIGHAM M1, CHAMPAGNE S1, THOMAS E2, BRYCE E3, ROSCOE D3, SHAW C1, WU W1, NG H1. for the BC Antimicrobial Resistance Surveillance Group. 1UBC Centre for Disease Control, 2 BC Women's and Children's Hospital and Vancouver General Hospital, Vancouver, BC.
D 3 In Vitro Development of Resistance to Novel Fluoroquinolones in Streptococcus pneumoniae and Molecular Characterization of Resistance Determinants
A. KOO, and P. JAYARATNE*. Hamilton Regional Lab. Med. Program and Dept. of Biology, McMaster University, Hamilton, ON.
D 4 Non-Hemolytic Streptococcus pyogenes: Invasive Infection and Prospective Survey
CIMOLAI, N., B.C.’s Children’s Hospital, Vancouver, B.C.
D 5 Molecular Epidemiology of Penicillin-Resistant Streptococcus pneumoniae (SP) in Canada
K.A. NICHOL1,* G.G. ZHANEL1,2 and D.J. HOBAN1,2
Health Sciences Centre1 and University of Manitoba, Winnipeg, Manitoba, Canada
P 35 Molecular Characterization and Mutant Prevention Concentration (MPC) Determination of Single-Step Fluoroquinolone (FQ)-Resistant Mutants of Streptococcus pneumoniae (SPN)
H.J.SMITH1,* K.A.NICHOL2, M.WALTERS1, G.G.ZHANEL1,2, D.J.HOBAN1,2, University of Manitoba1, and Health Sciences Centre1, Winnipeg, Manitoba, Canada
P 43 Invasive S. pneumoniae: Antimicrobial Susceptibility Patterns of British Columbia Isolates
D.L.ROSCOE*1, E.A.BRYCE1, C.SHAW2 , S. CHAMPAGNE2 AND MEMBERS OF THE BC ANTIMICROBIAL RESISTANCE SURVEILLANCE GROUP1. Vancouver Hospital and Health Sciences Centre and 2BC Centre for Disease Control Laboratory Services, Vancouver, British Columbia
P 51 Surveillance Program of Invasive Streptococcus pneumoniae Strains in the Province of Quebec from 1996 to 2000
L.P. JETT and The Pneumococcus Study Group. Laboratoire de sant publique du Quebec (LSPQ-INSPQ), Sainte-Anne-de-Bellevue (Quebec).
Chlamydia
(back to top)
P 25 Prevalence and Epidemiology of Chlamydia pneumoniae (CP) in a Family Practice Setting.
J.B. MAHONY1*, A. PETRICH1, J. MUNOZ2, D. PRICE2, J. KACZOROWSKI2, S. CHONG, M. SMIEJA1. McMaster University, Departments of Pathology and Molecular Medicine1, and Family Medicine2 and St. Joseph's Hospital, Hamilton, Ontario.
P 26 An association between chronic infection with Chlamydia pneumoniae and primary lung cancer
J.GNARPE*. H. GNARPE. H. KOYI. E. BRANDEN. B. STEEN. Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Institute of Medical Sciences, University of Uppsala, Department of Respiratory Medicine, Central Hospital, Department of Geriatrics, University of Gothenburg, Sweden.
P 27 Detection of Chlamydia pneumoniae in Peripheral Blood Mononuclear Cells and Sputum of Patients with Smoking-related Chronic Obstructive Pulmonary Disease.
A. PETRICH*, M. SMIEJA, R.LEIGH, S. CHONG, D. KAMADA, F.E. HARGREAVE, J.B. MAHONY. McMaster University, St. Joseph’s Healthcare, Hamilton, ON.
P 70 A Ligase Chain Reaction Testing Protocol for Detecting C. trachomatis and Amplification Inhibitors in Donated Semen
M. CHERNESKY,1 D. JANG,1 J. MURID2 AND A. DELVALLE2. St. Joseph's Hospital, McMaster University, Hamilton,1 ReproMed Ltd., Etobicoke,2 Ontario, Canada.
P 71 Is there a need to confirm positive results for Chlamydia trachomatis obtained by Cobas Amplicor CtNg?
R. GARCEAU1,* L. THIBAULT1, C. LAFORGE1, M. MALLET2, I Maclean3, Z. Mohammed3 1 Laboratoire de microbiologie, L’Hopital Regional Dr G.L. Dumont, 2Pehes et Oceans Canada, Moncton, NB, 3National Microbiology Laboratories, Health Canada, Winnipeg, MB.
P 72 The combined prognostic effect of Chlamydia pneumoniae IgA antibodies and D-dimer in acute coronary syndromes
JUDY GNARPE*. BRIAN WONG. WEI-CHING CHANG. PAUL W ARMSTRONG. Department of Medical Microbiology and Immunology and Department of Cardiology, University of Alberta, Edmonton, AB
Gonococci
(back to top)
P 79 Recovery of Neisseria gonorrhoeae from Amies Clear Transport Media Following Storage at Room Temperature or at 4ºC
C. TOMBLIN, J.*, ROY, J., HENWICK, S., PURYCH, D., BC Biomedical Laboratories, Surrey, BC.
G1 Ciprofloxacin and Macrolide Resistant Gonococci in Canada.
L.-K. NG,* I. MARTIN, P. SAWATZKY, L. BRYDEN and A. LAU. National Laboratory for Sexually Transmitted Diseases, National Microbiology Laboratory, Health Canada, Winnipeg, Manitoba, Canada
G2 Plasmid Mediated Antibiotic Resistance in Canadian Gonococci.
L. -K. NG,* I. MARTIN and A. LAU. National Laboratory for Sexually Transmitted Diseases, National Microbiology Laboratory, Health Canada, Winnipeg, Canada.
G3 Transport of Neisseria gonorrhoeae for Proficiency Testing Samples
NOBLE MA, KWOK E, FINN S. Clinical Microbiology Proficiency Testing program, Department of Pathology and Laboratory Medicine, University of British Columbia, and Starplex Scientific Inc., Etobicoke Ontario
G4 Potential Effective Plant-derived Antimicrobials Against Neisseria gonorrhoeae
1,2DILLON, J. R., * 2RAMIREZ-ARCOS, S., 3LOPEZ, A., 1CHARLAND, M. AND 3TOWERS, G. H. N. 1 Department of Biology, 2Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, K1N 6N5. 3Department of Botany, University of British Columbia,V6T 1Z4
G5 Detection of gyrA and parC Mutations in N. gonorrhoeae Using DNA Array Technology.
L.-K. NG, I. MARTIN and S. BOOTH.* National Laboratory for Sexually Transmitted Diseases, National Microbiology Laboratory, Health Canada, Winnipeg, Manitoba, Canada
Respiratory Infections
(back to top)
I 3 Incidence of Ventilator-Associated Pneumonia (VAP) In Three Canadian Intensive Care Units (ICU)
E.HENDERSON*, D.ZUEGE, P.BOITEAU, D.CHURCH, D.SANDHAM, T.LOUIE VAP PROJECT TEAM. Calgary Health Region University of Calgary, Calgary, Alberta.
I 1 An Outbreak of Respiratory Illness Due to Multiple Pathogens in a Complex Continuing Care (CCC) Setting
S. O'GRADY1*, K. WARK2, S. TEPPER1, W. MCCOLL1, E. CAMBLY1, P. CHAPLIN1, J. CONLY1,3, The Riverdale Hospital1, Toronto Public Health2, University Health Network and University of Toronto3, Toronto, ON
P 15 Needs Assessment for Guideline to Prevent Nosocomial Pneumonia
PIECKI,M.1*,JOHNSTON,B.L.2,OXLEY,C.1,KINGSBURY,L.1,LEDUC,S.1. 1 Health Canada, Ottawa, Ontario, 2 QE II Health Science Centre, Halifax, Nova Scotia.
P 49 Legionnaires Disease (LD) in Canada - January 1996 October 1997 evidence of regional disparity.
THOMAS J. MARRIE1, VICTOR YU2, JANET STOUT2, EMIDIO DECAROLIS3 and the Canadian Community-Acquired Pneumonia (CAP) Investigators. University of Alberta1; University of Pittsburgh2; Pfizer Canada Inc3.
Enteric Bacterial Disease
(back to top)
I 4 Control of a City-wide, Multi-hospital Outbreak of clindamycin-resistant C. difficile diarrhea
M.MAH, D.GREGSON, M.HULL, D.MACCANNELL, N.ALFIERI, R.READ, S.LONG, D.CHURCH and T.LOUIE Infection Control, Calgary Health Region & Faculty of Medicine, University of Calgary.
P 38 Antimicrobial Activity of a Soluble Bismuth/Cysteine Combination against Clostridium difficile
D. E. MAHONY1*, M. G. MORASH1, N. BURFORD2 AND S. J. O. V. VAN ZANTEN3.
Departments of Microbiology and Immunology1, Chemistry2 and Medicine3, Dalhousie University, Halifax, Nova Scotia
P 39 Molecular Epidemiology of Invasive Salmonella typhi in Southeast Turkey
HOSOGLU, S; LOEB, M; GEYIK, M.F; UCMAK, S; and JAYARATNE, P*. Dicle Univ. Hosp., Diyarbakir, Turkey; McMaster Univ. and Regional Lab. Med. Program, Hamilton, ON
P 50 PulseNet North: Canada's molecular subtyping network for enteric bacteria and its role in recent outbreaks of Salmonella and E. coli
MUNRO, J.*, CLARK, C., RODGERS, F., NLEP Health Canada, Winnipeg, MB.
P 78 In-vitro Comparative Study on the Killing Ability of Hypochlorite, Accelerated Hydrogen peroxide and Electrolysed Oxidizing Water on Clostridium difficile Spores
HARMER, B.W., JOHN, M.A.*, LANNIGAN, R and PETERS, G.T. Microbiology and Infection Control, London Health Sciences Centre, London, ON.
P 91 Laboratory Testing for Clostridium difficile (CD) Toxigenicity by Enzyme Immunoassay (EIA) Compared to Polymerase Chain Reaction (PCR)
S. CHAMPAGNE* , J. LEUSHNER, V. HAITS, M. KELLY. MDS Metro Laboratory Services, Burnaby, B.C.
P 92 Comparison of TechLab ToxA/B EIA (TAB) to Tissue Culture Assay in the Diagnosis of Clostridium difficile Associated Disease (CDAD)
W. WOODS,* K. RAMOTAR, P. JESSAMINE, B.TOYE. Division of Microbiology, Ottawa Hospital, Ottawa, Ontario.
P 94 Simultaneous Detection of Clostridium difficile and Clostridium perfringens Toxins in Faecal Specimens Using Personal LABTM Automated Microplate Analyzer and TECHLAB Elisa Kits in the Investigation of Antibiotic Associated Diarrhea.
CIEBIN B.,* TERRO R., RILEY G., SILVER A., SISON A., JAMIESON F., Central Public Health Laboratory, Toronto, Ontario, Canada.
P 95 Analysis of Clostridium difficile Susceptibility and Increased Screening for Clostridium difficile Associated Diarrhea in (CAD) in Saskatchewan
P. PIERONI, R. KITZUL, K. BRANDT, E. NAGLE, E. CHAN, and G. HORSMAN. Provincial Laboratory, Regina, Saskatchewan.
T 1 Characterization of an International Outbreak of Salmonella Enteritidis by Phage Typing in Canada. AHMED, R., DEMCZUK, W., OZUNKO, D., CLARK, C., WOODWARD, D., CIEBIN1, B., JAMIESON1, F., ISAACS2, S., and RODGERS, F. National Laboratory for Enteric Pathogens, National Microbiology Laboratory, Winnipeg, MB. 1 Central Public Health Laboratory, Etobicoke, ON. 2Div. of Enteric Food and Waterborne Diseases, Guelph, ON.
T2 Evaluation of LEUKO-STICK as a Diagnostic Tool for Distinguishing Non-Inflammatory from Inflammatory Infectious Diarrhoea
BEREND C. SCHIEVEN,1, J.H.BOONE2, J. CARNIATO1, AND D. FARRELL1. Gamma-Dynacare Laboratories, London, ON Canada1, TechLabR Inc., Blacksburg, VA2.
T3 A Food-borne Outbreak of Salmonella enteritidis in Ontario Related to Consumption of Contaminated Shelled Natural Almonds Imported from California
CIEBIN B.*1, BOLESZCZUK P.1, FOLLMI E.1, BARKER C.1, LABELLE J.1, AHMED R.2, RODGERS F.2, JAMIESON F.1 1Central Public Health Laboratory, Toronto, ON; 2National Laboratory for Enteric Pathogens, Health Canada, Winnipeg, MB
T4 Risk Factors for Campylobacter Infections in Estrie, Quebec: A Case-Control Study
MICHAUD, S.,*1 MENARD, S.,2 ARBEIT, R.D.3, 1Centre Hospitalier Universitaire de Sherbrooke, 2Direction de la Sant Publique de l'Estrie, Sherbrooke, QC, 3Boston University, Boston, MA.
T5 (presented as P83) Tracing the Transmission of Campylobacter Infections in Canada: Biotyping, Serotyping, Phage Typing and Molecular Typing.
WOODWARD, D.,* MOTERASSED, A., PRICE, L., MOSES, J., SCHWARTZ, J., AHMED, R., CLARK, C., and RODGERS, F. National Laboratory for Enteric Pathogens, Winnipeg, Manitoba.
Diagnosis & Prevention of Meningitis
(back to top)
P 1 Predictive Value of Normal Pediatric Cerebrospinal Fluid (CSF) Parameters for the Exclusion of Bacterial Meningitis
N. M. FERNANDES, B. MCTAGGART*, R. A. PENNIE. McMaster Univ. Med. Ctr., Hamilton, ON
P 2 Surveillance for nosocomial cerebrospinal fluid (CSF) shunt associated infections (NI) - a multicentre Canadian hospital prospective cohort study
LANGLEY J.M., GRAVEL D., EMBREE J., MATLOW A., MOORE D., CONLY J., MULVEY M., PATON S., Canadian Hospital Epidemiology Committee (CHEC) and the Canadian Nosocomial Infection Surveillance Program (CNISP)
P 3 Standardization of PFGE Protocol for Tracking N. meningitidis Outbreaks Across Canada
L. CHUI*, N. CHANG, F. JAMIESON, A. LI, J. ISMAIL and M. LORANGE Provincial Laboratory for Public Health Lab (Microbiology), Edmonton, Alberta, Central Public Health Laboratory, Toronto, Ontario; Laboratoire de Sant publique du Quebec/INSPQ , Quebec.
P 4 Characteristics of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001
RAYMOND S.W. TSANG, FRANCOISE COLLINS, and JAN STOLTZ. National Microbiology Laboratory, Population and Public Health Branch, Health Canada, 1015 Arlington Street, Winnipeg, Manitoba, R3E 3R2.
Investigation of Viral Meningitis in a Neonatal Unit
L. DAVIS,* T. VERMAAT, R. FANIZZA. The Scarborough Hospital, Grace Division TSH-GD, Scarborough, ON, A. MCGEER, Mount Sinai Hospital, Toronto ON, J. CAMPBELL, S. LEE. The National Centre for Enteroviruses, Halifax, NS, M. FEARON, Ontario Public Health Laboratory, Toronto, ON.
P 56 The Effect of PRP-T Conjugate Vaccine on Carriage of Haemophilus influenzae b and non-b among Day-Care Mexican Children
P. GOMEZ-DE-LEON 1,*, L.E. ESPINOSA 2, V. JIMENEZ 2, D. GOMEZ 2, J. SANTOS 1 and A. CRAVIOTO1 1Univ. Nacional Autuoma de Mexico; 2Hosp. Infantil de Mexico Federico Guez, Mexico, D.F.
P 58 Distribution of Carriage of Neisseria meningitidis (Nm) serogroups during an outbreak intervention for serogroup C disease
PATRICK D1, CHAMPAGNE S1, TAHA F1, ARSENAULT G2, SHAW C1, RAHIM T1, DUBENKO V1, ROMNEY M1, BIGHAM M1. UBC Centre for Disease Control and 2Fraser Valley Health Region.
Emerging Bacterial Pathogens
(back to top)
F 1 Molecular Characterization of Extended-Spectrum Beta-Lactamase Producing Organisms in Canadian Hospitals
M. R. MULVEY,1* E. BRYCE,2 R. HIZON,11 M. OFNER-AGOSTINI,3A.E. SIMOR,4S. PATON,5and the Canadian Hospital Epidemiology Committee (CHEC). 1National Microbiology Laboratory, Health Canada, Winnipeg, MB, Canada, 2Vancouver Hospital, Vancouver, BC, Canada, 3University of Toronto, Toronto, ON, Canada, 4Sunnybrook & Women's College HSC, Toronto, ON, Canada, 5CNISP, Health Canada, Ottawa, ON, Canada
F 2 Nosocomial Invasive Group A Streptococcal (IGAS) Infections: Eight Years Experience in Ontario, Canada
M. MCARTHUR, A. MCGEER*, DE. LOW, K. GREEN AND THE ONTARIO GROUP A STREPTOCOCCAL STUDY, Mount Sinai Hosp.
F 3 Characterization of an Epidemic Multidrug-Resistant (MDR) E.coli carrying a CTX-M-3 beta-lactamase
MP MULLER, D BOYD, A ASHI-SULAIMAN, C LAROCQUE, M MULVEY, D REYNOLDS, A MCGEER, BM WILLEY*, Dept. Microbiology, Mt. Sinai Hosp., Toronto; LCDC, Winnipeg; Dept. of Public Health, Durham, Canada
F 4 Enhanced Activity of Cefepime (CP) against 3rd Generation Cephalosporin-Resistant (3GCR) E. coli (EC) and Klebsiella spp. (KS)
K PIKE*, C LAROCQUE, MM KAPALA, GW SMALL, M SKULNICK, A MCGEER, DE LOW, BM WILLEY TML and Mount Sinai Hospital, Toronto Invasive Diseases Bacterial Network, University of Toronto, Toronto, ON, Canada
F 5 Epidemiology of Antimicrobial Resistant Organisms (ARO) in a Large Community Laboratory from British Columbia
S. CHAMPAGNE*, S. GERBASI, M. KELLY. MDS Metro Laboratory Services, Burnaby, B.C.
I 2 An Outbreak of Extended Spectrum Beta-lactamase (ESBL) Producing, Multi-Drug Resistant (MDR) E.coli in Long Term Care Facilities (LTCF)
M.P. MULLER*, A. MCGEER and the Durham-Toronto ESBL Outbreak Investigation Group
Antimicrobials
(back to top)
P 37 Outcomes Among Adults Treated with Cefazolin plus Tobramycin for Febrile Neutropenia
*DRESSER,L.D., McGEER, A.J.,Mt. Sinai Hospital, Toronto
P 84 In vitro activity of quipristine/dalfopristine (Synercid, SYN), telithromycin (TELI), linezolid (LIN), erythromycin (ERY), and clindamycin (CLIN) against coagulase-negative staphylococci (CoNS)
Z. HUSSAIN, C. PLETCH, M. A. JOHN.
Po 1 Antibiotic Utilization in an Inpatient Psychiatric Facility
JIM HUTCHISON, Health Care Corporation of St. John's and Memorial University of Newfoundland, St. John's, NF.
Po 2 What Family Physicians Recommend for Upper Respiratory Tract Infections: Results of the Antibiotics in Moderation (AIM) Pilot Project
ZOUTMAN, D., * FORD, D., BASSILI, A., LAM, M., NAKATSU, K., Queen's University, Kingston, ON
Po 3 Impacts of Feedback on Antibiotic Prescribing for Upper Respiratory Tract Infections: Results of the Antibiotics in Moderation (AIM) Pilot Project
ZOUTMAN, D., * FORD, D., BASSILI, A., LAM, M., NAKATSU, K., Queen's University, Kingston, ON
Po 4 Antibiotic (AB) Use and AB Resistance in Invasive pneumococcal disease (IPD) in Toronto, Canada
A. MCGEER, K. GREEN, L. LANDRY, E. GOLDENBERG, A. PLEVNESHI, TORONTO INVASIVE BACTERIAL DISEASES NETWORK, D.E. LOW, Mount Sinai Hosp. Toronto Medical Lab.
Po 5 Assessment of Antimicrobial Resistance in Enteric Pathogens Causing Gastroenteritis in Canada.
AHMED, R., DEMCZUK, W., SOULE, G., OZUNKO, D., WOODWARD, D., and RODGERS, F. National Laboratory for Enteric Pathogens, National Microbiology Laboratory, Winnipeg , Manitoba, Canada.
Parasitology & Vector Borne Disease
(back to top)
P 87 Genital Schistosomiasis in a Returning Traveller
TOMBLIN, J.*1, ARIKAN, Y.2, PURYCH, D.1, BONHAM, T.1, BC Biomedical Laboratories1, Surrey, BC and Royal Columbian Hospital2, New Westminster, BC.
P 93 Evaluation of the ProspecT Giardia / Cryptosporidium Microplate Assay (Alexon Trend) for the Detection of Giardia and Cryptosporidium in Fecal Samples
BROSNIKOFF,C*., and KOWALEWSKA-GROWCHOWSKA, K. Microbiology and Public Health, University of Alberta Hospitals, Edmonton, AB
H 1 Population Seroprevalence Kinetics during a Community Cryptosporidiosis Outbreak
J. ISAAC-RENTON1,2, J. PRIEST4, C.S. ONG1,2, S. MARION2, M. FYFE1,2, A. LI1, M. KHAN1, W.MOOREHEAD3, L. MEDD3, and P. LAMMIE4. BC Center for Disease Control1, University of British Columbia2, BC Ministry of Health3, Center for Disease Control and Prevention4, Atlanta.
H 2 Detection and Species Identification of Bartonella Species by a Specific PCR Based Method
G. JOHNSON, S. RICHARSON, *R. TELLIER The Hospital for Sick Children, Toronto, Ontario
H 3 Lyme Disease in Non-endemic Areas of Canada Linked to Borrelia burgdorferi-positive Blacklegged Ticks, Ixodes scapularis Dispersed by Birds
J. SCOTT1*, K. FERNANDO2, R. MANN2, J. ISAAC-RENTON2,3, M. MORSHED2,3 Lyme Disease Association of Ontario, Fergus, ON1, Zoonotic Diseases Emerging Pathogens, and Non-Viral Serology, Laboratory Services, BC Centre for Disease Control, Vancouver, BC2, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC3
H 4 Detection and Genetic Characterization of Granulocytic Ehrlichiae from Ixodes scapularis Ticks Collected in Canada
L.R.LINDSAY, M.DREBOT*, A. DIBERNARDO, H.ARTSOB, T.GALLOWAY. Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, PPHB, Health Canada, Winnipeg, MB. Department of Entomology, University of Manitoba, Winnipeg, MB.
H 5 The rrf (5S)-rrl (23S) Intergenic Spacer Region Sequence Data Revealed the Presence of Borrelia bissettii from Ixodes pacificus and Ixodes angustus Ticks
M. G. MORSHED*1,2, K. FERNANDO1, S. K. BYRNE1,2, R. CHEN1, R. MANN1, Q. WONG1 and J. L. ISAAC-RENTON1,2 1. Laboratory Services, B C Centre for Disease Control and 2. Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, B.C.
Surgical Site Infections
(back to top)
03 Alcohol Hand Disinfection as an Alternative to the Presurgical Scrub: One Hospital's Experience
D SPENCE*1, E.A. BRYCE2, A. WALSH2, L. HARRIS2, F.J. ROBERTS1 and S. SCHARF2. 1 British Columbia Cancer Agency and 2 Vancouver General Hospital, Vancouver, British Columbia
P 29 Surveillance of Surgeon Specific Surgical Site Infection (SSI) Rates for Cesarean Sections (CS)
D.WEINWURM,* K.OSTROWSKA, D.BHANGU, Trillium Health Centre (THC), 100 Queensway West, Mississauga, Ontario
P 30 Developing and implementing a Regional Surgical Site Infection Surveillance Program (RSSISP): Kudos and Crevasses
E.HENDERSON, N.ALFIERI, R.LAFRENIERE, M.MAH, T.LOUIE, INFECTION PREVENTION CONTROL PROGRAM. Calgary Health Region (CHR) & University of Calgary, Calgary, Alberta
P 65 Common Source Outbreak of Methicillin Sensitive Staphylococcus aureus (MSSA) Meningitis Following Neurotologic Surgery
BARRY, C., VEARNCOMBE, M.,* RUPNARAIN, E., HILTON, M., CHEN, J., LOUIE, L., SIMOR, A., Departments of Microbiology and Otorhinolaryngology, Sunnybrook and Women's College Health Sciences Centre (SWCHSC), University of Toronto, Toronto, ON
S 1 Surgical Site Infections in Cardiac Surgery and Intraoperative Dosing of Antimicrobial Prophylaxis
M. BUCHANAN-CHELL, B. SUTHERLAND, T. KIRKLAND, and G. TAYLOR University of Alberta Hospital and University of Alberta
S 2 Sensitivity of Community Health Nurses Reporting Caesarian Section Surgical Site Infections
YETMAN, M.,*1, MORALEJO, D.2, COFFIN, J.1 ; 1Health Care Corporation of St John's, NF, 2Memorial University School of Nursing, St John's, NF.
S 3 A Surveillance System for Surgical Site Infections in Spinal Surgery
F. ROBERTS, P. DOYLE*, M. DVORAK, C. FISHER, A. WALSH, P. WING, Vancouver Hospital and Health Sciences Centre.
S 4 Investigation of Surgical Site Infections(SSI)Following Liposuction Procedure.
LEDGERWOOD,D.*, LAU, W. LOUIE,T. Calgary Health Region, University of Calgary, Calgary Alberta.
S 5 Infection Related to External Ventricular Drains In Neurosurgery Patients
ANIELA M. DELA CRUZ, LYNORA SAXINGER, GEOFFREY TAYLOR University of Alberta Hospital
Planning for Microbiology Challenges
(back to top)
P 17 Transfusion Transmissible Infection - Responding to Krever
P.DOYLE1,2, M.BIGHAM3, D.PATRICK3, D. ROSCOE2, S.PECK4 Canadian Blood Services1 (CBS), Vancouver Hospital and Health Sciences Centre2, and British Columbia Centre for Disease Control3 (BCCDC), Vancouver, BC; Office of Provincial Health Officer4 (PHO) of British Columbia, Victoria, BC.
P 34 Canadian Involvement in Microbiology Laboratory Services in Kosovo
D.S.THOMPSON*, J.S.THOMPSON, H.RICHARDSON, R.ZOUTMAN, C.A.FLEMING. Thompson Consulting, Kirkfield, Kingston General Hospital, Kingston, and Quality Management Program Laboratory Services (QMPLS), Toronto, ON.
P 44 Planning for Exposure to Unusual Biological Agents; a Template for an Urban Response Plan
P.C.DALY*1, E.A.BRYCE2, W.BOWIE2, G.COSTANZA1, M.DEGRACE2, S.DOBSON3, J.ISAAC-RENTON4, H.MADDIGAN5, M.MORSHAD4 AND D.ROSCOE2. 1 Vancouver/Richmond Health Board, 2 Vancouver Hospital and Health Sciences Centre, 3 BC Children's and Women's Health Centre, 4BC Centre for Disease Control and 5 BC Ambulance Services.
P 101 Hospital Disaster Planning for Unusual Communicable Diseases - a Template for Immediate Management
E.A.BRYCE*1, M.DeGRACE 1, P.DALY2, G.CONSTANZO2, D.L.ROSCOE 1 and members of the Vancouver Biological Response Advisory Team. 1Vancouver Hospital and Health Sciences Centre and 2 Vancouver/Richmond Health Board, Vancouver, British Columbia
P 102 Response to Agents of Bioterrorism (BT) by Canadian laboratories: an update from the Health Canada Working Group
K. BERNARD* 1, M. FEARON3, H. ARTSOB1, M. HEISZ2, M. TEPPER2, THE HEALTH CANADA (HC) WORKING GROUP. HC-NML, WINNIPEG MB 1, HC-CEPR, OTTAWA ON2, PHL TORONTO3
Evaluations of Automated Equipment
(back to top)
P 19 A Head to Head Comparison Between Dade Behring MicroScan WalkAway 96 SI and bioM?ieux Vitek 2 Automated Identification Systems
P. PIERONI, S. WITT, E. NAGLE, E.CHAN AND G. HORSMAN. Provincial Laboratory, Regina, Saskatchewan.
P 20 Evaluation of the VITEK and MicroScan Synergy Tests for the Detection of High Level Gentamicin Resistance (HLGR) and Streptomycin Resistance (HLSR) in Enterococci
L. STOAKES*, V. MASSEY, E. ISAAC, G. LENNOX, V. FITZGERALD, R. LANNIGAN, Z. HUSSAIN. London Health Sciences Centre, London, Ontario, Canada.
P 21 Side by Side by Side Evaluation of BD-Phoenix, BioMerieux Vitek-2, and Dade MicroScan WalkAway 96 for Identification and Susceptibility Testing of Routine Clinical Isolates
TURNBULL, L.,* BROSNIKOFF, C., KASTNER, P., RENNIE,. University of Alberta Hospitals, Edmonton, AB.
P 22 Comparision of the BD Phoenix NMIC/ID-5 panel, the Vitek-I GNI card and the Cathra System for Accuracy in the Identification of Gram Negative Bacilli
BM WILLEY, Y RZAYEV, A ASHI-SULAIMAN, G BROWN, J TARBUSH, R MURPHY, M SKULNICK, DE LOW, A SARABIA TML and Mount Sinai Hospital, University of Toronto, and MDS Laboratories, Toronto, Ontario, Canada
P 23 Evaluation of the New Phoenix System to Detect 3rd Generation Cephalosporin (3GC) Resistance (R) in E. coli (EC) and Klebsiella spp (KS)
MA KAPALA, C LAROCQUE, GW SMALL, K PIKE, M SKULNICK, DE LOW, A MCGEER, BM WILLEY* TML and Mount Sinai Hospital, Toronto Invasive Bacterial Diseases Network, University of Toronto, ON, Canada
P 24 Oxacillin Susceptibility Testing of Coagulase-negative Staphylococci (CoNS) Using the Disk Diffusion Method (DD) and the Vitek GPS 105 Card (V105)
W. WOODS,* P. LEM, P. JESSAMINE, B. TOYE, and K. RAMOTAR. Division of Microbiology, The Ottawa Hospital, University of Ottawa, Ontario, Canada.
Quality Assurance
(back to top)
P 12 Experience of an Interdisciplinary, International Special Interest Group on Health Care Quality Improvement
BIRNBAUM, D., Dept. of Health Care & Epidemiology, University of British Columbia, Vancouver, BC, and the SHEA/ASQ HEALTH CARE QUALITY SPECIAL INTEREST GROUP.
P 73 Does Concentration Method Affect Performance on Enteric Parasitology Proficiency Testing Samples? A Five Year Review
C.A. FLEMING*, J. PALMER, K.C. KAIN, D.W. MACPHERSON, A.M.R. MACKENZIE, H. RICHARDSON AND THE MICROBIOLOGY COMMITTEE Quality Management Program - Laboratory Services, Toronto, Ontario
P 74 Slow improvement in PT performance with ESBL reporting 1996-2000
MICHAEL A NOBLE, SHIRLEY NIKIFORUK, and the Clinical Bacteriology Committee, Clinical Microbiology Proficiency Testing (CMPT), Department of Pathology and Laboratory Medicine, University of British Columbia.
P 75 Quality Control Standards for Sterilizers Located Outside the Central Sterile Supply Area
M. WALKER*1, E.A.BRYCE1, L.HARRIS1, D.TRUDEAU2 1. Division of Medical Microbiology and Infection Control and 2. Sterile Supply Department, Vancouver General Hospital, Vancouver, B.C.
Infection Control
(back to top)
L1 Routine Cleaning Methods for Reprocessing of Triple-Lumen Sphinctertomes that are Single-Use Devices may leave Patient Secretions in the Wire Channel
ALFA M.J.,* R. NEMES
L2 Reuse of critical and semi-critical single-use medical devices (SUMeDs) in Canada
MILLER MA, GRAVEL D, PATON S, the Canadian Hospital Epidemiology Committee (CHEC), the Canadian Nosocomial Infection Surveillance Program (CNISP).
L3 Stability of Endotoxin on Exposure to Moist Heat
JAMES L. WHITBY, University of Western Ontario
L4 Benefit of a Silver Alloy, Hydrogel-Coated Latex Urinary Catheter (SSCATH) in a Community Hospital
DICKSON,* T. Langley Memorial Hospital, South Fraser Health Region, Langley, B.C.
L5 Microbial Contamination of Enteral Feed Administration Sets in a Pediatric Institution
A. MATLOW, R. WRAY, R. FREEMAN, C. GOLDMAN, L. STREITENBERGER. Hospital for Sick Children and University of Toronto, Toronto, ON
O 1 Sharps Injury Reduction Using the Reusable SharpSmart Containerisation System
TERRY GRIMMOND, Clinical Director, The Daniels Corporation International, 3 Tarbett Rd Hamilton, New Zealand. RICK CREECH, Risk Manager, The Canberra Hospital, Canberra Australia, CAROL TAYLOR, OH S Unit, Royal Prince Alfred Hospital Sydney Australia, RAYLEE PANDUR, ICO Maroondah Hospital Melbourne, Australia, RIEMKE KAMPEN, ICO Calvary Hospital Canberra Australia, WENDY KABLE, ICO Canterbury Hospital Sydney Australia, PAT MEAD, ICO, Mercy Hospital Auckland New Zealand, TERRY RINGS, ICO, South Auckland Health, Auckland New Zealand, PETER MACKIE, Risk Manager, St Johns Hospital, Livingston Scotland. Presenter's Email: terry@daniels.com.au.
O 2 Loaps and Sotions: A Regional Hand Washing Initiative
K. Pauling-Shepard* and G. Meyers Calgary Health Region (CHR)
O 4 To Wash Or Not To Wash: Understanding Hand Washing Behaviour
G.MEYERS*, E.HENDERSON, D.MORALEJO, T.LOUIE, T.DALBY and K.DUREGON. Calgary Health Region (CHR), University of Calgary and Memorial University
O 5 The Use Of A Bathing Program For Containment And Reduction Of MRSA In A Residential Care Setting: A Case Study
NOBLE MA and RATZLAFF J. Microbiology and Infection Control, George Pearson Centre, Vancouver Hospital and Health Sciences Centre, Vancouver BC
P 11 Case-based Learning: A Practical Approach in Teaching Infection Control to Large Groups
M. WALKER, S. SCHARF, A. WALSH* Division of Medical Microbiology and Infection Control, Vancouver General Hospital, Vancouver, British Columbia
P 13 Evaluation of Selection of Isolation Precautions and Development of an Educational Tool
M. RENAUD,* L. BOURGEOIS, D. MOORE, Montreal Children's Hospital, McGill University Health Center, Montreal, QC
P 14 Surveillance Technology In the Palm of Your Hands
HIRJI, Z.*, PYKE, M., CONLY, J., GARDAM, M. University Health Network, Toronto, Ontario
P 16 Management of Bordetella pertussis Exposure in the Health Care Worker
DAVEY, F. BsN, RN, CIC Victoria General Hospital, #1 Hospital Way, Victoria, BC, V8Z 6R5.
P 17 Transfusion Transmissible Infection - Responding to Krever
P.DOYLE1,2, M.BIGHAM3, D.PATRICK3, D. ROSCOE2, S.PECK4 Canadian Blood Services1 (CBS), Vancouver Hospital and Health Sciences Centre2, and British Columbia Centre for Disease Control3 (BCCDC), Vancouver, BC; Office of Provincial Health Officer4 (PHO) of British Columbia, Victoria, BC.
P 18 Adaptation of Health Canada Revision of Isolation and Precaution Techniques (July 1999)
DR. E. THOMAS, N. MAZINKE, B. BALASKI, D. NORTON; Regina Health District, Regina, SK.
P 28 Incidence Of Blood Stream Infection In A Multicenter Cohort Of Hemodialysis Patients
TAYLOR, D. GRAVEL, L. JOHNSTON, J. EMBIL, M. ISHAK, D. HOLTON, S. PATON, the Canadian Hospital Epidemiology Committee and the Canadian Nosocomial Infection Surveillance Program
P 31 Antibacterial polymer skin shield: Superior performance?
FOSTER M., MARTIN N., Grand River Hospital, Kitchener, Ontario
P 32 Surveillance For Hemodialysis Related Blood Stream Infections In Canadian Hemodialysis Centres
G. TAYLOR, D. GRAVEL, L. JOHNSTON, J. EMBIL, M. ISHAK, D. HOLTON, S. PATON, the Canadian Hospital Epidemiology Committee and the Canadian Nosocomial Infection Surveillance Program
P 33 Ultrasound (U/S) Gel - A Potential Source of Microbiologic Contamination
PYKE, M, HIRJI, Z,* HAVILL, D, RAWLINSON, G, BURT, J, CONLY, J and GARDAM, M. Infection Prevention and Control Unit (IPAC), University Health Network (UHN), Toronto, Ontario.
P 36 Effectiveness of a Thermal Fused Broad-Spectrum Interactive Iodinated Polymer for Use in Wound Dressings in Preventing Colonization and Infection of Skin and Soft Tissue.
BOURGET, S.1,*GENDRON, A.M.1, ST-LOUIS, J.P.1, MESSIER, P. J.2 1 Hydro Biotech, Division of Triosyn Corp., Mirabel, QUE.& 2 Triosyn Corp., South Burlington, VT.
P 40 Impact of Silver-Coated Urinary Catheters on Nosocomial Urinary Tract Infection Rates
S. CALLERY RN MHSc CIC; M. GRIFFITHS-TURNER MLT* St. Joseph’s Healthcare Hamilton, Ontario, Canada.
P 52 Evolution of Antimicrobial Resistance in Nosocomial Gram Positive Pathogens in Ontario, Canada
CA FLEMING, K. GREEN, H. RICHARDSON, M. SAGINUR, DE. LOW, A. MCGEER Mount Sinai Hosp., Quality Management Program-Laboratory Services (QMP-LS), Ontario.
P 76 Clinical Waste Trends
TERRY GRIMMOND, Clinical Director, The Daniels Corporation International. 3 Tarbett Rd Hamilton, New Zealand.
P 96 Resources for Infection Control in Canadian Acute Care Hospitals: Results of the Resources for Infection Control in Hospitals (RICH) Project
ZOUTMAN, D.,*FORD, D., CANADIAN HOSPITAL EPIDEMIOLOGY COMMITTEE, CANADIAN NOSOCOMIAL INFECTION SURVEILLANCE PROGRAM , Queen's University, Health Canada
P 98 Getting the Word Out
STAMP E* REG. N. DAVID THOMPSON Regional Laboratory Infection Prevention and Control, Red Deer Regional Hospital Centre, Red Deer AB
Student Posters
(back to top)
SP 1 Temporal Relationship Between Respiratory Syncytial Virus (RSV) Outbreak and Geographic Location in Northern Alberta and the Northwest Territories
SPAVOR M. L.,*VAUDRY W. Division of Infectious Diseases, Department of Pediatrics, University of Alberta, Edmonton, Alberta
SP 2 Pseudomonas aeruginosa in Cystic Fibrosis: Are Standard Susceptibility Criteria Relevant for Inhaled Antibiotics?
*LABIRIS,R., GROVES,D., PETRICH,A., FREITAG,A., STEVENS,D., MACLEOD,S., St. Joseph's Hospital and McMaster University, Hamilton, ON.
SP 3 Outbreak of Cyclospora cayetanensis Gastroenteritis Associated with Consumption of Imported Thai Basil, Vancouver, British Columbia, May 2001
L. HOANG*1, J. HARB2, C. Ong1, M. FYFE2. 1Department of Laboratory Medicine, University of British Columbia, Vancouver, BC; 2Epidemiology, BC Centre for Disease Control, Vancouver, BC.
SP 4 A Comparison Study of Infections in Oncology and Haematology Patients with Hickman Catheters
HAYWARD,B.* H.C.C.S.J., General Hospital Site, St. John's, Newfoundland.
SP 5 The Northern Alberta Experience with Coccidioidomycosis
J.R.MINSOS, B.Sc.*, T.J.MARRIE, M.D., L.J.MIEDZINSKI, M.D. Infectious Diseases, University of Alberta Hospital, Edmonton, AB.
SP 6 Surprises from an Observational Study of Antibiotics Used to Treat Ambulatory Community-Acquired Pneumonia in an Emergency Room Setting
C. MALCOLM,* T. J. MARRIE, and the CHAP-CAP INVESTIGATORS. Department of Medicine, University of Alberta Hospital, Edmonton, AB.
SP 7 Changes in Practice Related to the Prevention of Early Onset (EO) Neonatal Group B Streptococcal Disease at Mount Sinai Hospital
R. LOVINSKY, L. LANDRY and A. MCGEER. University of Toronto and Mount Sinai Hospital, Toronto, Ontario
SP 8 Methicillin Resistant Staphylococcus aureus (MRSA): is it possible to prevent hospital transmission in an endemic area?
DELIGNE B.*, BOURGAULT A.M., LAROSE A., TURGEON P., FLEURY C., VINCELETTE J., GAUDREAU C., LAMOTHE F. Hopital St-Luc du CHUM, Montreal, Quebec.
SP 9 Six Month Prospective Surveillance of Central Venous Catheter Complications.
DELIGNE B.*, LAROSE A., BOURGAULT A.M. Hopital Saint-Luc du CHUM, Montreal, Quebec.
SP 10 Molecular Characterization of Fluoroquinolone (FQ)-Resistant Canadian Clinical Isolates of Streptococcus pneumoniae (SPN)
H. J. SMITH1,* K. A. NICHOL2, A. WALKTY 1, G.G. ZHANEL 1,2, D.J. HOBAN 1,2 University of Manitoba1 and Health Sciences Centre2, Winnipeg, Manitoba, Canada
SP 11 Nosocomial Infections in a Geriatric Short-Stay Department.
DELIGNE B.*, A.M. BOURGAULT, C. KISSEL A. LAROSE. Hopital Saint-Luc du CHUM, Montreal, Quebec.
SP 12 Mycobacterium neoaurum bacteremia in a haemodialysis patient
M. BECKER1, A. SUCHAK2, R. ZARYCHANSKI2, J. WOLFE 3,4, C. TURENNE3, A. KABANI 2,3,4. 1McMaster University, Hamilton, ON; 2 University of Manitoba, Winnipeg, MB; 3 National Reference Centre for Mycobacteriology, National Microbiology Laboratory, Health Canada, Winnipeg, MB; 4 Clinical Microbiology Laboratory, Health Sciences Centre, Winnipeg, MB.
SP 13 Tuberculosis Prophylaxis
V.MURLEY,L'OREILLY,G.VICTOR Dept of Medicine, University of Ottawa, Ottawa Hospital-General Campus, Ottawa Ontario
SP 14 Listeria Monocytogenes: Absence Of Synergism Between Ampicillin And Gentamicin Using E-Test And Checkerboard Microdilution Techniques
I. DAVIS, N. CAMPBELL, M.CURRIE, W. F.SCHLECH, Div. of Infectious Diseases, Dalhousie University, Halifax
SP 15 Distribution of Non-tuberculous Mycobacteria in Alberta from 1993-2000
CHANDRAN, A. U. and FANNING, E.A., University of Alberta Hospital, Edmonton, AB
